CryoPort, Inc. (NASDAQ:CYRX) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Key Points

• Analysts give CryoPort a “Moderate Buy” consensus: Seven of nine covering brokerages rate the stock a buy, with an average 1-year price target of $18.00.
• Several firms recently raised their price targets, including BTIG Research to $25, Roth Capital to $21 and Craig Hallum to $20.
• CryoPort reported quarterly revenue of $48.97 million, above estimates, but missed earnings expectations with an EPS loss of $0.20; the company continues to post negative margins and return on equity.

Shares of CryoPort, Inc. (NASDAQ:CYRX - Get Free Report) have been given a consensus rating of "Moderate Buy" by the nine brokerages that are presently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and seven have given a buy recommendation to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $18.00.

CYRX has been the topic of a number of analyst reports. Craig Hallum raised their target price on shares of CryoPort from $15.00 to $20.00 and gave the stock a "buy" rating in a research report on Wednesday, June 3rd. Roth Capital reiterated a "buy" rating and issued a $21.00 price target on shares of CryoPort in a report on Friday, August 7th. KeyCorp increased their price target on CryoPort from $15.00 to $17.00 and gave the stock an "overweight" rating in a research note on Wednesday, May 20th. Needham & Company LLC increased their price target on CryoPort from $15.00 to $19.00 and gave the stock a "buy" rating in a research note on Friday, August 7th. Finally, BTIG Research raised their price objective on CryoPort from $17.00 to $25.00 and gave the stock a "buy" rating in a report on Friday, July 24th.

CryoPort Stock Performance

Shares of CYRX stock opened at $15.55 on Monday. The firm has a 50-day moving average price of $15.68 and a 200 day moving average price of $13.07. CryoPort has a twelve month low of $7.61 and a twelve month high of $17.20. The company has a market capitalization of $787.61 million, a price-to-earnings ratio of -17.28 and a beta of 1.89.

CryoPort (NASDAQ:CYRX - Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported ($0.20) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.19) by ($0.01). The firm had revenue of $48.97 million for the quarter, compared to analyst estimates of $48.18 million. CryoPort had a negative return on equity of 7.20% and a negative net margin of 20.05%. As a group, research analysts predict that CryoPort will post -0.83 earnings per share for the current year.

Insiders Place Their Bets

In related news, CEO Jerrell Shelton sold 28,800 shares of the stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $14.91, for a total transaction of $429,408.00. Following the transaction, the chief executive officer directly owned 1,201,814 shares in the company, valued at approximately $17,919,046.74. This represents a 2.34% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 9.50% of the company's stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Basepoint Wealth LLC acquired a new stake in shares of CryoPort in the fourth quarter worth approximately $34,000. Tower Research Capital LLC TRC raised its stake in CryoPort by 300.1% during the second quarter. Tower Research Capital LLC TRC now owns 5,833 shares of the company's stock worth $44,000 after purchasing an additional 4,375 shares during the period. Creative Planning acquired a new position in shares of CryoPort in the 2nd quarter valued at $96,000. Quadrature Capital Ltd purchased a new stake in shares of CryoPort during the 4th quarter valued at $97,000. Finally, State of Wyoming increased its holdings in shares of CryoPort by 30.2% during the 2nd quarter. State of Wyoming now owns 14,218 shares of the company's stock worth $106,000 after buying an additional 3,301 shares during the last quarter. Institutional investors and hedge funds own 92.90% of the company's stock.

About CryoPort

Cryoport, Inc NASDAQ: CYRX provides temperature-controlled logistics and supply-chain solutions for the life sciences industry. The company supports the transportation, storage and management of sensitive biological materials, including cell and gene therapies, biologics, vaccines, clinical-trial materials and reproductive tissues.

Its offerings include specialized cryogenic and refrigerated shipping systems, monitoring and tracking technologies, logistics coordination, packaging and storage services, and related bioservices.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.